Prihlásiť sa Zaregistrujte sa zadarmo

Pomer krátenia spoločnosti Alimera Sciences

Aká je hodnota metriky Pomer krátenia spoločnosti Alimera Sciences?

Hodnota metriky Pomer krátenia spoločnosti Alimera Sciences Inc. je 3.54

Aká je definícia metriky Pomer krátenia?



Pomer krátenia (Short ratio) je pomer akcií predaných na krátko a priemerným denným objemom.

Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.

The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.

Pomer krátenia spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Alimera Sciences

Čomu sa venuje spoločnosť Alimera Sciences?

alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.

Firmy s metrikou pomer krátenia podobnou spoločnosti Alimera Sciences